Department of Orthopaedics, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, 1 Hoppin St, Providence, RI, 02903, USA.
Providence VA Medical Center, Providence, RI, 02908, USA.
Adv Healthc Mater. 2018 Jun;7(11):e1701407. doi: 10.1002/adhm.201701407. Epub 2018 Mar 15.
The meniscus is the most commonly injured structure in the human knee. Meniscus deficiency has been shown to lead to advanced osteoarthritis (OA) due to abnormal mechanical forces, and replacement strategies for this structure have lagged behind other tissue engineering endeavors. The challenges include the complex 3D structure with individualized size parameters, the significant compressive, tensile and shear loads encountered, and the poor blood supply. In this progress report, a review of the current clinical treatments for different types of meniscal injury is provided. The state-of-the-art research in cellular therapies and novel cell sources for these therapies is discussed. The clinically available cell-free biomaterial implants and the current progress on cell-free biomaterial implants are reviewed. Cell-based tissue engineering strategies for the repair and replacement of meniscus are presented, and the current challenges are identified. Tissue-engineered meniscal biocomposite implants may provide an alternative solution for the treatment of meniscal injury to prevent OA in the long run, because of the limitations of the existing therapies.
半月板是人类膝关节中最常见受伤的结构。半月板缺失会由于异常机械力而导致进展性骨关节炎(OA),并且该结构的置换策略落后于其他组织工程努力。挑战包括具有个体化尺寸参数的复杂 3D 结构、所遇到的显著压缩、拉伸和剪切载荷以及较差的血液供应。在本进展报告中,提供了对不同类型半月板损伤的当前临床治疗方法的综述。讨论了这些治疗方法的细胞疗法和新型细胞来源的最新研究。综述了临床可用的无细胞生物材料植入物和无细胞生物材料植入物的当前进展。提出了用于半月板修复和置换的基于细胞的组织工程策略,并确定了当前的挑战。组织工程半月板生物复合材料植入物可能为治疗半月板损伤提供一种替代解决方案,以防止长期 OA,因为现有疗法存在局限性。